Septerna, Inc. Common Stock
SEPN •
Sell Open
Signal type
Sell
Status
Open
Open Price
$22.83
Stop Loss
$25.47
Performance
-5.69%
Days Open
2
Signal Setup
Signal Type Sell
Status Open
Open Date Apr 13, 2026
Open Price $22.83
Stop Loss $25.47
Timespan Day
Company Profile
Name Septerna, Inc. Common Stock
Ticker SEPN
Market Cap $470.98M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $24.13
List Date Oct 25, 2024
Description
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Website Open Company Website